Literature DB >> 32765702

MicroRNA-19a-3p inhibits the cellular proliferation and invasion of non-small cell lung cancer by downregulating UBAP2L.

Yuejiang Pan1, Ke Jin1, Xuan Xie1, Kexi Wang1, Huizhong Zhang1.   

Abstract

MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  cell proliferation; invasion; microRNA-19a-3p; migration; non-small cell lung cancer; ubiquitin associated protein 2 like

Year:  2020        PMID: 32765702      PMCID: PMC7401917          DOI: 10.3892/etm.2020.8926

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.751


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

Authors:  Victor Ambros
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.

Authors:  Altaf A Dar; Shahana Majid; David de Semir; Mehdi Nosrati; Vladimir Bezrookove; Mohammed Kashani-Sabet
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

Review 4.  Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.

Authors:  Matthew G Oser; Matthew J Niederst; Lecia V Sequist; Jeffrey A Engelman
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

Review 5.  Delivering the promise of miRNA cancer therapeutics.

Authors:  Diane M Pereira; Pedro M Rodrigues; Pedro M Borralho; Cecília M P Rodrigues
Journal:  Drug Discov Today       Date:  2012-10-11       Impact factor: 7.851

6.  Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.

Authors:  Tao Ye; Jing Xu; Ling Du; Wenhui Mo; Yiming Liang; Jinglin Xia
Journal:  Cell Physiol Biochem       Date:  2017-03-27

7.  MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.

Authors:  Xiaoying Zhang; Yafang Chen; Pan Zhao; Li Zang; Zhiqing Zhang; Xiaofang Wang
Journal:  Leuk Lymphoma       Date:  2016-11-10

8.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

9.  Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro.

Authors:  Bing Zhao; Gang Zong; Yongsheng Xie; Jia Li; Hongliang Wang; Erbao Bian
Journal:  Int J Mol Med       Date:  2015-08-24       Impact factor: 4.101

Review 10.  Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review).

Authors:  Ralph Zinner; Carla Visseren-Grul; David R Spigel; Coleman Obasaju
Journal:  Int J Oncol       Date:  2015-10-29       Impact factor: 5.650

View more
  6 in total

Review 1.  Ubiquitin Binding Protein 2-Like (UBAP2L): is it so NICE After All?

Authors:  Lucile Guerber; Evanthia Pangou; Izabela Sumara
Journal:  Front Cell Dev Biol       Date:  2022-06-20

2.  Prognostic nomogram for surgery of lung cancer in HIV-infected patients.

Authors:  Lin Wang; Liwei Wu; Jianjian Liu; Laiyi Wan; Hui Chen; Yijun Zhu; Jun Wang; Hongwei Li; Lei Shi; Leilei Li; Yanzheng Song
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

3.  Fibulin 2 Is Hypermethylated and Suppresses Tumor Cell Proliferation through Inhibition of Cell Adhesion and Extracellular Matrix Genes in Non-Small Cell Lung Cancer.

Authors:  Yunxia Ma; Miljana Nenkov; Desiree Charlotte Schröder; Mohamed Abubrig; Nikolaus Gassler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

4.  Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1α axis.

Authors:  Hua Tian; Tiao Qiang; Jinbo Wang; Li Ji; Bo Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation.

Authors:  Zheng Wang; Anqi Sun; Aihui Yan; Jian Yao; Haibo Huang; Ziming Gao; Tao Han; Jia Gu; Ni Li; Huizhe Wu; Kai Li
Journal:  Mol Cancer       Date:  2022-04-02       Impact factor: 27.401

6.  The microRNA miR-19a-3p suppresses cell growth, migration, and invasion in multiple myeloma via the Wnt/β-catenin pathway.

Authors:  Zhengxiao Wei; Wang Wang; Qingfeng Li; Linfang Du; Xuemei He
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.